Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 11, 2019
Tubulis and Glycotope announced that they have signed a research and feasibility agreement, providing Glycotope access to Tubulis’ proprietary antibody drug conjugate (ADC) technologies.
read more
Tuesday, October 03, 2017
TraceLink announced Tubilux has selected its serialization solutions to help its European pharmaceutical manufacturing customers comply with the rapidly approaching serialization deadlines for the EU FMD.
read more
TTP plc has entered into a technology advisory partnership with Cancer Research UK.
read more
Thursday, December 12, 2019
TTP Labtech has announced its corporate name change to SPT Labtech effective from January 6, 2020.
read more
Tuesday, January 17, 2023
TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient ...
read more
Integra Pharma Solutions has formally withdrawn its EUA application in connection with its partner’s manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit from consideration in response to FDA guidance.
read more
Trxade announced that its Bonum Health subsidiary has launched a B2B platform which bundles telehealth, a COVID-19 risk assessment tool and a PPE purchasing tool, through a secure mobile dashboard for corporate clients.
read more
Trovagene has entered into an agreement with AstraZeneca to provide Trovera® urine ctDNA biomarker test and services.
read more
Trovagene has formally engaged PRA Health Sciences to conduct Trovagene's Phase 1b/2 clinical trial of PCM-075, a polo-like kinase 1 inhibitor, in patients with AML.
read more
Trovagene has executed a supplier agreement with NerPharMa, to manufacture drug product for PCM-075.
read more
Wednesday, October 03, 2018
Trovagene has entered into an exclusive patent license agreement with the Massachusetts Institute of Technology (MIT).
read more
Triumvira Immunologics announced a strategic relationship with the Centre for Commercialisation of Cancer Immunotherapy (C3i).
read more
TriRx Pharmaceutical Services, LLC, a leading international CDMO, hosted Kansas Lt. Governor David Toland, Shawnee Mayor Michelle Distler, State Senator Mike Thompson, Congresswoman Jo Ella Hoye, Congresswoman Cindy Neighbor, other Shawnee city ...
read more
Tuesday, February 08, 2022
TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced today that it has finalized and closed on its agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of its manufacturing site in Speke, ...
read more
Triphase Accelerator and Catalent announced interim results for Triphase Accelerator's multi-center, open-label, monotherapy study of TRPH-222 in heavily pre-treated patients with relapsed and/or refractory B-cell lymphoma.
read more